Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-10

Clinical Trial Update: Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update discusses mesenchymal stem cell therapy for conditions of the femoral head, including osteonecrosis and osteochondritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Jianming Tan | Conditions: Osteochondritis of the Femoral Head | EARLY_Phase 1 | Status: UNKNOWN